Table of Contents
I. Applications
- A. Basic Research Applications
- 1. Directed Differentiation of Autologous MSCs towards Intra-Mesenchymal
Lineages
- 2. Directed Differentiation of Autologous MSCs towards Extra-Mesenchymal
Lineages
- B. Supporting Hematopoietic Cells
- C. Cell-Based Therapy Applications
- 1. Gene Transfer Applications
- 2. Allogenic Transplantation
- 3. Applications of MSCs for Osteochondral Repair
- 4. Applications of MSCs for Myocardiac Repair
- 5. Therapeutic Potential beyond Mesenchymal Lineages
- D. Use of MSC in 3-D Scaffolds for Tissue Engineering Applications
II. Application Priorities
- A. Overall
- B. By Segment
- 1. Academic
- 2. Biotech
- 3. Pharma
III. Potential Labs/Customers
- A. General MSC Research Labs
- B. Osteogenic-Focused Research Labs
- C. Myogenic and Myocardial-Focused Research Labs
- D. Adipogenic-Focused Research Labs
- E. Neuronal-Focused Research Labs
- F. Immunology-Focused Research Labs
- G. Commerical Labs
- H. NIH Labs
IV. Companies Offering Human MSC Research Products, including Products Offered
- A. Stem Cell Technologies
- B. Thermo Scientific
- C. Invitrogen
- D. Celprogen
- E. ScienCell Research Laboratories
- F. Abcam
- G. BD Biosciences
- F. Millipore
V. Companies Offering Rodent MSC Research Products, including Products Offered
- A. Cell Applications
- B. Millipore
- C. Celprogen
- D. Cyagen Biosciences
- E. ScienCell Research Laboratories
VI. Projected 5-Year Market Growth
- A. Scientific Publication Trend Analysis
- B. Grant Rate Trend Analysis
- C. Patent Trend Analysis
VII. Mesenchymal Stem Cells as Tools for Drug Discovery
- A. Companies Developing Toxicology Screening Platforms for Stem
Cells
- B. Advantages of Using Human MSCs for Drug Screening
- C. Potential Drug Screening Advantages of Rodent MSCs
- 1. Acquisition, Handling, and Differentiation Advantages
- 2. Genetic Manipulation of MSCs
- 3. Potential for Genetically Engineered MSC Reporter Lines
VIII. Advantages of Serum Free Supplements for Use in MSC Research
IX. Research Product Opportunities and Suggestions
- A. MSCs Derived from Alternative Sources than Bone Marrow
- B. Novel RMSC Differentiation Kits
- C. Mesenchymal Stem Cell Expansion Media
- D. Mesenchymal Stem Cell Markers
- E. Mesenchymal Growth Factors
- F. Monoclonal Antibodies and Kits for Phenotyping RMSCs
- G. Chips for MicroArray Analysis of Gene Expression in RMSCs
X. Conclusions |
Related Report
|